DXCM Q3 2024 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$994M+2.0% YoY

Gross Profit

$594M59.7% margin

Operating Income

$152M15.3% margin

Net Income

$135M13.5% margin

EPS (Diluted)

$0.34

QoQ Revenue Growth

-1.0%

Cash Flow

Operating Cash Flow

$200M

Free Cash Flow

$88M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$6.4B

Total Liabilities

$4.4B

Stockholders' Equity

$2.0B

Cash & Equivalents

$621M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$994M	$975M	+2.0%
Gross Profit	$594M	$623M	-4.7%
Operating Income	$152M	$206M	-26.0%
Net Income	$135M	$121M	+11.5%

Geographic Segments

UNITED STATES

$702M71%

Non-US

$292M29%